Feed

Franklin Templeton (BEN) State Street Corporation Revolution Medicines

Biotech Sector Remains Attractive to Investors Following Significant Recovery

Investors in the biotechnology sector are maintaining a positive outlook following significant gains this year, driven by factors such as potential mergers and acquisitions and a recovery in clinical trials. The performance of key ETFs and specific companies, like Revolution Medicines, highlights the sector's resilience and growth potential.